Fertility News and Research

RSS

Miracle boy born after new infertility therapy

A Lancashire couple Andrew and Louise Riley have been blessed with a “miracle baby boy” thanks to a pioneering new genetic screening process. Elliott Riley was born just after Christmas after the Rileys opted for a relatively new technique called array comparative genomic hybridisation (CGH) after 10 years of infertility treatments. Mrs. Riley, 37, and her husband, 39, said they were delighted to welcome Elliott on December 30.

3 Feb 2011

Miracle baby after radical new procedure for uterine fibroids

Amy Cordle is the first woman in Australia to become a mother after undergoing a radical new procedure. On Australia Day, the 31-year-old Albert Park woman’s little “miracle” arrived when daughter Neroli was born.

3 Feb 2011

Merck announces publication of GARDASIL pivotal Phase III study data in NEJM

Merck announced today that data from the pivotal Phase III study with GARDASIL in males were published in the February 3 issue of the New England Journal of Medicine.

3 Feb 2011

Study uncovers genetic hierarchy in plant sperm formation

Biologists at the University of Leicester have published results of a new study into the intricacies of sex in flowering plants.

3 Feb 2011

Uterine health is more relevant for fetus to achieve normal birth weight, full gestation

For women seeking pregnancy by assisted reproductive technologies, such as in-vitro fertilization, a new study shows that the health of the uterus is more relevant than egg quality for a newborn to achieve normal birth weight and full gestation.

2 Feb 2011

New data shows Shady Grove Fertility financial programs make testing, treatment more affordable

New data shows Shady Grove Fertility Center's financial programs -- designed to help make infertility testing and treatment more affordable -- helped more than a quarter of patients proceed with treatment in 2010, despite the year's significant economic challenges.

29 Jan 2011

Maternal deaths related to IVF are a key indicator of risks to older women

Although still rare, maternal deaths related to in vitro fertilisation (IVF) are a key indicator of risks to older women, those with multiple pregnancy and those with underlying disease, warn experts in an editorial published on bmj.com today.

28 Jan 2011

ESHRE publishes position paper on intrafamilial medically assisted reproduction

The European Society of Human Reproduction and Embryology (ESHRE) has published today (Thursday) a position paper related to intrafamilial medically assisted reproduction (IMAR).This particular type of assisted reproduction can raise various ethical and controversial issues, due to the involvement of a family member as a third party.

20 Jan 2011

New long-term survival data from OPUS, CRYSTAL studies demonstrate strong tumor shrinkage of Erbitux

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today highlighted a further analysis of the large randomized Phase II OPUS study demonstrating an association between early tumor shrinkage and long-term median overall survival (OS) of more than 2 years for patients with KRAS wild-type metastatic colorectal cancer (mCRC) treated with Erbitux® (cetuximab) plus FOLFOX standard chemotherapy.

19 Jan 2011

Antioxidants may cause fertility problems in females

Antioxidants are sold over the counter everywhere. They're added to food, drink and face cream. But according to Prof. Nava Dekel of the Biological Regulation Department, we still don't have a complete understanding of how they act in our bodies. New research by Dekel and her team, recently published in the Proceedings of the National Academy of Sciences USA (PNAS), has revealed a possible unexpected side effect of antioxidants: They might cause fertility problems in females.

19 Jan 2011

IntegraMed acquires Northwest Center for Reproductive Sciences

IntegraMed America, Inc., the leader in developing, marketing and managing specialty healthcare facilities in the fertility and vein care markets, announced today that is has acquired Northwest Center for Reproductive Sciences (NCRS).

18 Jan 2011

Annual Society for Endocrinology BES conference to take place in UK from 11-14 April 2011

The annual Society for Endocrinology BES conference is taking place in Birmingham, UK from 11-14 April 2011.

18 Jan 2011

Lifetime tool for families created through sperm donation

Starting a family the "old-fashioned way" is becoming less common. Only 25% of American households are made up of a husband, wife, and a child. The fertility field is continually growing with advances in scientific technology, and infertile patients have more options for conceiving -- including the use of donor sperm. Along with the medical advances comes the continual need for emotional support for both the parent and children.

14 Jan 2011

Vitrolife receives patent protection for Swemed Sense needle in European markets

Swemed Sense™ is a unique needle that is used for the collection of oocytes in connection with IVF. The approved patent means that Vitrolife has both design protection and product patent protection for Swemed Sense™ in strategically important European markets. A patent has also been applied for in other prioritized markets.

14 Jan 2011

BPA more harmful to women with hormonal and fertility imbalances

A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM), found higher Bisphenol A (BPA) levels in women with polycystic ovary syndrome (PCOS) compared to controls. Furthermore, researchers found a statistically significant positive association between male sex hormones and BPA in these women suggesting a potential role of BPA in ovarian dysfunction.

13 Jan 2011

Scientist develops FMR1 genetic blood test for predicting IVF outcomes

A researcher at Albert Einstein College of Medicine of Yeshiva University has helped to develop the first genetic blood test for predicting the chances that in vitro fertilization will lead to a successful pregnancy.

13 Jan 2011

CE mark approves Vitrolife's SpermFreeze Solution

SpermFreeze Solution, which is used for freeze storage of sperm, has obtained a CE mark and is thereby approved for sales within the European Economic Area.

12 Jan 2011

FDA accepts Merck's JANUMET extended-release formulation NDA for type 2 diabetes

Merck today announced that the New Drug Application (NDA) for the Company's investigational extended-release formulation of JANUMET for type 2 diabetes has been accepted for standard review by the U.S. Food and Drug Administration (FDA). The Company is also moving forward as planned with regulatory filings in countries outside the United States.

12 Jan 2011

Proposed health research agency for UK

According to the Academy of Medical Sciences, a new body to regulate all health research in the UK should be established. The authorities suggest that the current regulatory system was dysfunctional and thus hampering medical advances and they blame red tape for the decline in the UK’s share of clinical research. The report suggests creating a Health Research Agency that would make approving projects quicker and cheaper. According to Health Secretary for England, Andrew Lansley, the government would consider how the recommendations could be implemented.

11 Jan 2011

Shady Grove Fertility and Cade Foundation grant help paralyzed patient and wife deliver healthy baby boy

Shady Grove Fertility Center is pleased to announce the birth of Collin James Sharp, born December 8, 2010 to Jennifer and David Sharp of Richmond, VA. The 7 lb. 15 oz baby boy's birth was made possible through a partnership of Shady Grove Fertility and the Cade Foundation.

11 Jan 2011